Jackson Creek Investment Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jackson Creek Investment Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$764
-50.3%
16,620
-37.9%
0.32%
-47.5%
Q2 2023$1,538
+58.6%
26,758
+3.4%
0.62%
+51.1%
Q1 2023$970
-99.9%
25,877
-6.2%
0.41%
+12.1%
Q3 2022$775,000
-28.1%
27,577
-4.4%
0.36%
-16.7%
Q2 2022$1,078,000
-39.7%
28,837
-42.1%
0.44%
-33.2%
Q1 2022$1,788,000
+160.6%
49,814
+36.1%
0.65%
+110.0%
Q3 2020$686,00036,5900.31%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders